← Leaderboards
Phuoc T. Tran
University Of Maryland Baltimore
$8,297,853
Attributed
$13,992,451
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,934,609 · 11
By mechanism
U54$9,156,706 · 6
U01$7,090,462 · 2
R01$3,319,361 · 2
R21$368,080 · 1
Top collaborators
- Christine L. Hann8 shared
- Luigi Marchionni8 shared
- Andrew Josef Ewald7 shared
- Elana Fertig7 shared
- Aleksander S. Popel7 shared
- Amit Sawant4 shared
- Nicole L Simone4 shared
- Christopher Dennis Mcfarland2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Christopher Dennis McFarland$1,467,438
- Susan F. Keay$2,425,976
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTumorInnovationCellsMouse ModelRadiationIn VivoRecurrenceRadiation TherapyCollaborationsProgramsMalignant NeoplasmsResponseMalignant Neoplasm Of ProstateIn VitroPhenotypePre-ClinicalCancer ModelResearch DesignBiologyPathway InteractionsPatternRadiation OncologistBase
Grant awards (41)
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center$1,505,442
U54 · FY2025 · CA
Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC$599,214
R01 · FY2025 · CA · contact PI
Administrative Core$353,585
U54 · FY2025 · CA · contact PI
Radiation modulation of cell plasticity programs determine prostate cancer oligometastatic potential$285,152
U54 · FY2025 · CA · contact PI
Phase 2 randomized Total Eradication of metastatic lesions following definitive Radiation to the Prostate in de novo oligometaStatic prostate cancer (TERPS) trial$222,758
U54 · FY2025 · CA · contact PI
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center$1,428,096
U54 · FY2024 · CA · contact PI
Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC$494,498
R01 · FY2024 · CA · contact PI
Administrative Core$353,368
U54 · FY2024 · CA · contact PI
Phase 2 randomized Total Eradication of metastatic lesions following definitive Radiation to the Prostate in de novo oligometaStatic prostate cancer (TERPS) trial$203,906
U54 · FY2024 · CA · contact PI
Radiation modulation of cell plasticity programs determine prostate cancer oligometastatic potential$169,262
U54 · FY2024 · CA · contact PI
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center$1,474,945
U54 · FY2023 · CA · contact PI
Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC$541,670
R01 · FY2023 · CA · contact PI
Administrative Core$346,513
U54 · FY2023 · CA · contact PI
Radiation modulation of cell plasticity programs determine prostate cancer oligometastatic potential$279,450
U54 · FY2023 · CA · contact PI
Phase 2 randomized Total Eradication of metastatic lesions following definitive Radiation to the Prostate in de novo oligometaStatic prostate cancer (TERPS) trial$217,408
U54 · FY2023 · CA · contact PI
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center$1,533,675
U54 · FY2022 · CA · contact PI
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC$599,374
U01 · FY2022 · CA
Integrating bioinformatics into multiscale models for hepatocellular carcinoma$593,322
U01 · FY2022 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC$368,438
U01 · FY2022 · CA
Phase 2 randomized Total Eradication of metastatic lesions following definitive Radiation to the Prostate in de novo oligometaStatic prostate cancer (TERPS) trial$367,352
U54 · FY2022 · CA · contact PI
Radiation modulation of cell plasticity programs determine prostate cancer oligometastatic potential$285,153
U54 · FY2022 · CA · contact PI
Administrative Core$130,641
U54 · FY2022 · CA · contact PI
Integrating bioinformatics into multiscale models for hepatocellular carcinoma$68,259
U01 · FY2022 · CA
Integrating bioinformatics into multiscale models for hepatocellular carcinoma$675,084
U01 · FY2021 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC$598,229
U01 · FY2021 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC$368,438
U01 · FY2021 · CA
Tumor-barcoding coupled with high-throughput sequencing of a novel chemoradiation resistant SCLC mouse model$153,517
U01 · FY2021 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC$611,606
U01 · FY2020 · CA
Integrating bioinformatics into multiscale models for hepatocellular carcinoma$608,149
U01 · FY2020 · CA
Integrating bioinformatics into multiscale models for hepatocellular carcinoma$43,359
U01 · FY2020 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC$593,258
U01 · FY2019 · CA
Integrating bioinformatics into multiscale models for hepatocellular carcinoma$589,905
U01 · FY2019 · CA
A pre-clinical x-ray/optical tomography-guided radiation research platform for pancreatic cancer$154,413
R21 · FY2019 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC$611,606
U01 · FY2018 · CA
Integrating bioinformatics into multiscale models for hepatocellular carcinoma$607,918
U01 · FY2018 · CA
A pre-clinical x-ray/optical tomography-guided radiation research platform for pancreatic cancer$213,667
R21 · FY2018 · CA
Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer$335,670
R01 · FY2017 · CA · contact PI
Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer$335,670
R01 · FY2016 · CA · contact PI
Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer$341,833
R01 · FY2015 · CA · contact PI
Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer$334,656
R01 · FY2014 · CA · contact PI
Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer$336,150
R01 · FY2013 · CA · contact PI